rituximab
roche,biogen
[]
banik et al. mtx as induction and maintenance for localised gpa. 48% in remission at 1 year. 39% required rtx. #acr22 abstr#1082 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC